Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-17

FDA Approved: TEMAZEPAM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Temazepam from Amneal Pharmaceuticals LLC under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)